however, made any negative comments on this issue; on the contrary, several women commented that they thought this kind of study important. Our investigation was considered and approved by all the concerned research ethics committees. CONCLUSIONS We conclude that most of the participants in this trial had been informed, but in many cases the information did not follow the guidelines of the Declaration of Helsinki. One third of the participants had not been aware that they had the option of withdrawing their participation at any time. There were systematic differences between the various participating clinics in that certain clinics were better at informing their patients than others. Our Design-Prospective study of pregnant women at high risk of developing an affective psychosis after childbirth. Clinical assessments in pregnancy and after delivery were made by using a semistructured interview (schedule for affective disorders and schizophrenia) and psychiatric illnesses were categorised according to operational criteria (research diagnostic criteria).
Objective-To test the hypothesis that affective psychosis after childbirth is associated with an altered sensitivity to dopaminergic stimulation.
Design-Prospective study of pregnant women at high risk of developing an affective psychosis after childbirth. Clinical assessments in pregnancy and after delivery were made by using a semistructured interview (schedule for affective disorders and schizophrenia) and psychiatric illnesses were categorised according to operational criteria (research diagnostic criteria).
Setting-Obstetric and psychiatric departments in and around Greater London. Subjects-29 pregnant women with a history of bipolar or schizoaffective psychosis and 47 control pregnant women. Of these, 16 from each group participated in a growth hormone challenge test and the results for 15 women in each group were analysed.
Interventions-On the fourth day postpartum women participating in the hormone challenge test were given a subcutaneous injection of a small dose (0005 mg/kg) of the dopamine agonist apomorphine.
Main outcome measures-Growth hormone secretion in response to apomorphine as an index of the functional state of hypothalamic dopamine receptors.
Results-Eight ofthe 15 women at risk ofpsychosis subsequently had a recurrence of illness (five bipolar, one schizomanic, and two major depressive illnesses); these women had significantly greater growth hormone responses to apomorphine than the seven at risk women who remained well and the 15 controls, and there were no significant differences between groups in average baseline growth hormone concentrations. The mean (SD) concentrations for women with recurrence, women at risk who remained well, and control women respectively
Introduction
Childbirth is a potent precipitator of severe mental illness: a woman is about 20 times more likely to require admission to hospital for a psychotic illness in the month after delivery than in any month in the previous two years. ' Women with a history of affective psychosis, related or unrelated to childbirth, are particularly vulnerable, and relapse rates of 50% have been reported. Prospective investigations of such women through pregnancy and the postpartum period therefore permit rigorous evaluation of putative aetiological mechanisms. 3 Of all the endocrine changes taking place after parturition, the sharp fall in circulating sex steroid hormone concentrations is perhaps most likely to contribute to the precipitation of psychosis in predisposed women. Unlike most other hormones steroids have easy access to the brain and concentrations of oestradiol and progesterone in plasma and cerebrospinal fluid are highly correlated.4 Recent research has shown that oestrogens modulate the function of monoaminergic and, in particular, dopaminergic neurotransmitter systems in the central nervous system.56 Abnormalities of dopaminergic neurotransmission have been implicated in both schizophrenic and manic depressive illness, and Cookson has proposed that puerperal psychosis is triggered by the effects of postpartum oestrogen withdrawal on central dopaminergic functions. In clinical investigations the secretion of growth hormone in response to a small dose of the dopamine agonist apomorphine has been used as an index of the responsiveness of dopamine sensitive neurones (probably via D2 receptors) in the hypothalamus or elsewhere in the brain. 8 All subjects were interviewed at 36 weeks of pregnancy and at six months post partum by using the schedule for affective disorders and schizophrenia.9 Interview data were supplemented by information from hospital case notes. Past psychiatric episodes and postnatal relapses were categorised according to the research diagnostic criteria. '0 The postnatal period was defined as the first 90 days after delivery.
The fourth day after delivery was chosen for the neuroendocrine investigation because, on the one hand, it allowed a period of recovery during which drugs given during labour would be mostly cleared and, on the other hand, because it was expected to fall into the characteristic "lucid interval" before the onset of the acute psychosis. The mood state at the start of the test was assessed by using one of a series of visual analogue scales with "happy" as 0 and "sad" as 100 on a 100 mm scale which the subject completed before the first blood sample was taken. Plasma growth hormone concentrations were assayed immunoradiometrically by using a proprietary kit (Novo BioLabs, United Kingdom). The growth hormone standards of the kit were calibrated against the international reference preparation (66/217). The results of the growth hormone assays were calculated from these standards and are expressed in mU/l. At growth hormone concentrations of 9-0, 24-0, and 46-0 mU/l intra-assay and interassay coefficients ofvariation were 6 5%, 7 1%, and 5 5% and 9 4%, 8 5%, and 9-6%, respectively.
Results
The 16 The average baseline growth hormone concentrations were similar in the three groups. The area under the growth hormone response curve was calculated by subtracting the average baseline concentration from the average concentration after the administration of apomorphine. Average baseline concentrations were also subtracted from the absolute peak values to obtain peak increases. Because the variance of increases in peak and average growth hormone concentrations was significantly different among the three groups the data were transformed logarithmically before all statistical tests. The women who had recurrence of psychosis had significantly greater growth hormone responses (peak increases and average increases) to apomorphine than those at risk who remained well and their peak increases were also significantly greater than those of the controls. Of the two women who experienced a recurrence of major depression, one had an increased growth hormone response and one did not. There was no difference in the growth hormone responses between the at risk women who remained well and the controls.
Within the group of women with a recurrence the four who seemed to have mild prodromal symptoms at the time of the test did not differ in their growth hormone responses from the other four women (mean (SD) peak increase 13-58 (11-71) and 13-76 (15-95) mU/l, t= -0.50, df=6, not significant; average increase 5-42 (4-71) and 8-08 (9-37) mU/l, t=0 00, df=6, not significant). The 15 at risk women taken together rated themselves on the mood scale as less happy than the controls, but the mood scores of those with subsequent recurrence were not different from those who remained well. Mood ratings did not correlate with the growth hormone responses (Pearson's correlation coefficient r=0 05, n=29 for peak increase in growth hormone and r=0-08, n=29 for average increase, both not significant). Subjects were also split into two groups according to median mood score (33-69 mm, n= 29), and there was no significant difference in peak growth hormone response (t= -0-18, df=27) and average growth hormone increase (t=-0d19, df=27) between the two groups. It seems unlikely, therefore, that the enhanced growth hormone responses in women with recurrence of psychosis were a reflection of affective or behavioural changes at the time of the test.
Twelve at risk women had been treated with neuroleptic drugs in the past (7/8 women with recurrence and 5/7 who remained well, data on one subject who remained well were not available). The length of time that these women had stopped taking neuroleptic drugs did not correlate with their growth hormone responses (Pearson's correlation coefficient r=-0 33, n= 12 for peak increase in growth hormone concentration and r= -0 36, n= 12 for average increase, both not significant), and there was also no difference between subjects if they were split into two groups according to median time not taking neuroleptics (median=27 months, t= 1 -24, df= 10 for peak increase, and t=1-21, df=10 for average increase, both not significant). Antiemetic or opiate drugs given during labour and delivery had no effect on growth hormone responses either within the control group (for antiemetics t=0-33, df= 13 for peak increase and t=0 13, df= 13 for average increase; for opiates t= -0-02, df= 13 and t= -0-26, df= 13, not significant) or when the responses of control and at risk subjects were analysed together (t=0-36, df=28, t=0 05, df= 13 and t=0 58, df=28, t=-0-78, df=28, not significant, respectively).
Discussion
The growth hormone response to the dopamine agonist apomorphine was enhanced on the fourth day after delivery in women who were about to have a recurrence of affective psychosis. The significance of the presence of mild prodromal symptoms in half of these subjects is uncertain and in future studies tests at different times after delivery are needed. Previous neuroendocrine investigations of dopaminergic function in affective illnesses have yielded conflicting results and may have been influenced by confounding factors such as incomplete withdrawal from drugs, weight loss, and other non-specific effects of a severe mental illness. I3 The strategy of investigating high risk subjects just before they are likely to become severely ill avoids these problems. However, some other variables which could have confounded our results need to be considered.
In the prodromal phase of puerperal psychosis women often have appreciable insomnia. We did not measure this, but if some of the subjects with a subsequent recurrence of psychosis had less sleep before the test this would have reduced rather than enhanced the growth hormone response to apomorphine.'4 Breast feeding was not permitted during the test, and breast feeding before the test could also not have accounted for differences in endocrine responsiveness: only two at risk subjects did not attempt to breast feed -one relapsed and one did not. Within the control group there were no differences in mean (SD) growth hormone concentrations between the nine breast feeding women and the six bottle feeding women (baseline 0-64 (0 32) and 1-26 (2 15) mU/l, t= -0-38, df= 13; peak increase 4-00 (4 30) and 2 54 (3 14) mU/l, t=0-78, df=13; average increase 1-60 (2-32) and 1 10 (1-71) mU/1, t=0 34, df=13; all comparisons were not significantly different).
BMJ VOLUME 303 14 SEPTEMBER 1991 Apomorphine is thought to increase growth hormone secretion by stimulating postsynaptic dopamine receptors, probably of the D2 type, in the median eminence of the hypothalamus.s There is evidence that the sensitivity of these receptors or of some associated intracellular mechanism is influenced by female sex steroid hormones. Thus the growth hormone response to apomorphine is enhanced in women taking oral contraceptives '6 and 82 , and we are sure that the whole medical profession on this side of the Atlantic will join with us in wishing many happy returns of the day to the graceful poet, the genial essayist, and the venerable ex-professor ofanatomy, who has done more than any man living to prove that there is no necessary incompatibility between medicine and literature. This is a truth which in these days, when the literary element is being more and more thrust aside in the education of medical students, needs such a conspicuous example as that of Dr. Holmes to reinforce it, and all those medical men who have what may without offence be called a soul above their stethoscopes, and who are anxious not to see medicine lose the rank which it has so long held as one of the "learned" professions, should be deeply grateful to him for having shed the lustre ofletters over our somewhat dismal science. Though he has long retired from active practice it is gratifying to learn that the Muses whom he has wooed so successfully have not been able to banish the love of medicine from his heart. He still continues to take the keenest interest in everything connected with the good repute and dignity ofthe profession which it may be hoped he will continue to adorn for many a long year. Not many months ago the editor of The Australasian Medical Gazette, having forwarded to Dr. Holmes copies of the evidence taken by the Select Committee of the Legislative Council of New South Wales, relative to the practice ofmedicine in that colony, received from him the following letter, which we need make no apology for giving in full:-Boston, April 25th, 1891 MY DEAR SIR,-I thank you most cordially for the very important and interesting papers relating to quackery as it appears in your great colony.
Although it is a very long time since I have practised medicine, I retain my interest in all matters relating to the profession, and am glad to add these valuable documents to my library, for the present, but to go eventually with the rest of my medical books, which I gave some years ago to the Boston Medical Library.-Believe me, dear Sir, very truly and gratefully yours.
The Hon. John M. Creed, Sydney. OLIVER WENDELL HOLMES.
(British MedicalJ7ournal 1891;ii:655)
